National Cancer Center Hospital East

Institution (Healthcare)

Homepage ROR

Also Known As

National Cancer Center Hospital East, 国立がん研究センター東病院

16.3K

Publications

1.5M

Citations

1.3K

Authors

977

Concepts

About

National Cancer Center Hospital East is a healthcare institution in Kashiwa, Japan known for medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	96	2.2K	125.6K
2	Engineering	48	494	25.6K
3	Arts	7	21	1.5K
4	Education	5	6	272
5	Language Studies	1	1	282

National Cancer Center Hospital East

16.3K

Publications

1.5M

Citations

Page 1

	Year	Citations
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma Tony Mok, Yi‐Long Wu, Sumitra Thongprasert, New England Journal of Medicine	2009	8.2K
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova, The Lancet Surgical OncologyChemotherapy Versus ChemotherapyGastrointestinal OncologyMedicineGastroenterology	2010	7.2K
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma Richard S. Finn, Shukui Qin, Masafumi Ikeda, New England Journal of Medicine	2020	6.8K
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, New England Journal of Medicine	2016	4.9K
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Eric Van Cutsem, Andrés Cervantes, René Adam, Annals of Oncology Surgical OncologyEsmo Consensus GuidelinesGastrointestinal OncologyMedicineCancer Management	2016	3.3K
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study Barbara Burtness, Kevin J. Harrington, Richard Greil, The Lancet Neoadjuvant TherapyChemotherapy Versus CetuximabMedicinePathologyHead And Neck Cancer	2019	3K
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial Axel Grothey, Eric Van Cutsem, Alberto Sobrero, The Lancet OncologyGastrointestinal OncologyRegorafenib MonotherapyClinical TrialsColorectal Cancer	2012	2.8K
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study Aurélien Marabelle, Dung T. Le, Paolo A. Ascierto, Journal of Clinical Oncology	2019	2.8K
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer Thierry André, Kai‐Keen Shiu, Tae Won Kim, New England Journal of Medicine	2020	2.8K
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial Yelena Y. Janjigian, Kohei Shitara, Markus Moehler, The Lancet Chemotherapy Versus ChemotherapyEsophageal CancerGastrointestinal OncologyMedicineCheckmate 649	2021	2.7K

Page 1